Syngene International Limited has informed the Exchange regarding a press release dated March 19, 2025, titled "Syngene concludes the acquisition of Biologics Manufacturing Facility from Emergent BioSolutions Inc.".
Syngene International Limited has informed the Exchange regarding a press release dated March 19, 2025, titled "Syngene concludes the acquisition of Biologics Manufacturing Facility from Emergent BioSolutions Inc.".